Trade Mark Journal No.2026/016 17 April 2026
UK00004362536 26 March 2026 (5,9,42)
RNARISE
- Class 5
- Vaccine adjuvants; Vaccines; Vaccine preparations; Vaccines against flu; Viral vaccines; Human vaccine preparations; Vaccines for cattle; Oral vaccine preparations; Vaccines against pneumococcal infections; Veterinary vaccines; Vaccines for horses; Vaccines for human use; Antiviral drugs for treating influenza; Pharmaceutical preparations for the treatment of viral diseases; Veterinary vaccines for bovine animals; Antivirals; Antiviral antibiotics; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the treatment of autoimmune diseases; Medicines for prevention against milk fever; Pharmaceutical products for the treatment of infectious diseases; Viral antigens; Foot rot vaccines; Pharmaceutical preparations for the prevention of autoimmune diseases; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for immunity adjustment.
- Class 9
- Machine learning software for healthcare.
- Class 42
- Biotechnology research; Research and development in the pharmaceutical and biotechnology fields; Biotechnology testing; Consultancy in the field of biotechnology; Research relating to biotechnology; Research and development in the field of biotechnology; Biotechnological research relating to agriculture; Biotechnological research; Design services relating to plant for the biotechnology industry; Biotechnological research relating to industry; Research of pharmaceuticals; Biotechnological research relating to the petroleum industry; Biotechnological research relating to horticulture; Pharmaceutical research services; Pharmaceutical research and development services; Laboratory research services relating to pharmaceuticals; Research in the field of telecommunication technology; Research relating to molecular sciences; Research and development services in the field of antibody technology; Biotechnology research for determining the neuronal survival of molecules in animal models; Research relating to pharmaceuticals; Scientific research in the field of genetics and genetic engineering; Pharmaceutical drug development services; Scientific research relating to genetics of plants; Research and testing services in the fields of bacteriology and virology; Biomedical research services; Laboratory services for biomanufacturing; Biology consultancy; Scientific research in the field of genetics; Industrial research; Software as a service [SaaS] featuring software for machine learning; Software as a service [SaaS] services featuring software for machine learning, deep learning and deep neural networks.
CamMed Therapeutics Ltd.